Kenneth Lim

9PUBLICATIONS
51CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical biotechnology diagnostics (incl. biosensors)Radiation therapyCellular immunologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 26, 2026
Early Treatment Failure in Patients Receiving Ciltacabtagene-Autoleucel for Relapsed/Refractory Multiple Myeloma.

|Jun 08, 2026
Real-world application of the International Myeloma Society (IMS)/International Myeloma Working Group (IMWG) consensus on genomic staging for high-risk multiple myeloma: A report from the Australia and New Zealand Myeloma and Related Diseases Registry.

|Apr 22, 2026
A multicenter study of progression risk and outcomes in solitary bone plasmacytoma with and without marrow involvement.

|Apr 10, 2026
Diagnosis and management of immune effector cell-associated enterocolitis after ciltacabtagene autoleucel.

Kenneth Jc Lim, Hee Eun Lee, Zongming Eric Chen

|Dec 31, 2025
Clinical course, risk factors and mitigating strategies for Immune effector cell-associated late onset neurotoxicities after ciltacabtagene autoleucel CAR-T in multiple myeloma.

Kenneth J C Lim, Melinda Tan, Ricardo Parrondo

|Aug 21, 2023
The prognostic impact of t(11;14) in multiple myeloma: A real-world analysis from the Australian Lymphoma Leukaemia Group (ALLG) and the Australian Myeloma and Related Diseases Registry (MRDR).

Kenneth Jc Lim, Cameron Wellard, Dipti Talaulikar

Pageof 2

Frequent Collaborators

4 joint publications

Rafael Fonseca

4 joint publications

Saurabh Chhabra

4 joint publications

Morie Gertz

4 joint publications

Moritz Binder